Tuberculosis vaccines: Beyond bacilli Calmette-Guérin

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin

Tuberculosis (TB) disease caused by Mycobacterium tuberculosis (M. tb) remains one of the leading infectious causes of death and disease throughout the world. The only licensed vaccine, Mycobacterium bovis bacille Calmette-Gue ́rin (BCG) confers highly variable protection against pulmonary disease....

Bibliografski detalji
Glavni autor:	McShane, H
Format:	Journal article
Jezik:	English
Izdano:	2011

Slični predmeti

Tuberculosis vaccines: beyond bacille Calmette–Guérin
od: McShane, H
Izdano: (2011)

Molecular diagnosis of childhood tuberculosis and infection with Bacilli Calmette-Guerin in Taiwan
od: Ruwen Jou, i dr.
Izdano: (2011-12-01)

Bacille Calmette-Guérin Vaccination and Tuberculosis
od: Nick R Anthonisen
Izdano: (2005-01-01)

Phosphodiesterases Inhibition by Bacilli Calmette-Guérin Contributes to Decrease Asthma in Allergic Rats
od: Yajuan Wang, i dr.
Izdano: (2011-09-01)

Oral bacillus Calmette-Guérin vaccine against tuberculosis: why not?
od: Renata Monteiro-Maia, i dr.
Izdano: (2014-09-01)

Timeliness of Bacilli Calmette-Guérin vaccination among infants in a tertiary health facility in sub-Saharan Africa
od: Ekop EE, i dr.
Izdano: (2021-07-01)

Effectiveness of bacillus Calmette–Guerin vaccination history on pulmonary tuberculosis symptoms
od: Safar Farajnia, i dr.
Izdano: (2019-12-01)

The Use of Bacille Calmette-Guérin vaccination in Children
od: David P Speert
Izdano: (1995-01-01)

Bacillus Calmette-Guerin (BCG): the adroit vaccine
od: Oluwafolajimi A. Adesanya, i dr.
Izdano: (2021-02-01)

Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette–Guérin vaccination
od: Sayori Kobayashi, i dr.
Izdano: (2021-08-01)

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guérin
od: Minassian, A, i dr.
Izdano: (2012)

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin.
od: Minassian, A, i dr.
Izdano: (2012)

Next-Generation Vaccines Based on Bacille Calmette–Guérin
od: Natalie E. Nieuwenhuizen, i dr.
Izdano: (2018-02-01)

Beyond Tuberculosis: The Surprising Immunological Benefits of the Bacillus Calmette–Guérin (BCG) Vaccine in Infectious, Auto-Immune, and Inflammatory Diseases
od: Magdalena Jurczak, i dr.
Izdano: (2025-02-01)

The management and outcome of Bacillus Calmette–Guérin vaccine overdose
od: Sung-Hsi Wei, i dr.
Izdano: (2018-04-01)

Sternal osteomyelitis after bacillus Calmette-Guérin vaccination
od: Rolandas Selvestravičius, i dr.
Izdano: (2016-09-01)

Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine
od: Helen A. Fletcher
Izdano: (2016-09-01)

Penile tuberculosis following intravesical Bacille Calmette-Guérin immunotherapy
od: Anadi Roy Chowdhury, i dr.
Izdano: (2013-01-01)

The Lack of Association Between Bacille Calmette-Guerin Vaccination and Clustering of Aboriginals with Tuberculosis in Western Canada
od: Victoria J Cook, i dr.
Izdano: (2005-01-01)

Newly sequenced genomes of four Bacillus Calmette Guerin vaccines
od: Maria Carolina Sisco, i dr.
Izdano: (2020-05-01)

Bacillus Calmette–Guérin and Bladder Cancer
od: Azad H.A. Razack
Izdano: (2007-10-01)

Positive impact of rescheduling Bacillus Calmette-Guérin vaccination on vaccinations at birth
od: Simmi Oberoi, i dr.
Izdano: (2017-01-01)

Factors influencing the efficacy of Bacille Calmette-Guérin (BCG) vaccine
od: Lwandile Bukula, i dr.
Izdano: (2025-03-01)

Bacillus calmette–Guérin scar inflammation after COVID vaccination
od: B N Shiva Prasad
Izdano: (2022-01-01)

Childhood lupus vulgaris after Bacillus Calmette–Guérin vaccine
od: Sarah Hamdy Soliman, i dr.
Izdano: (2023-01-01)

The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy
od: Patricia Méndez-Samperio
Izdano: (2019-06-01)

Erythema at the bacillus Calmette-Guerin scar after influenza vaccination
od: Yanin Chavarri-Guerra, i dr.
Izdano: (2019-12-01)

Bacillus Calmette-Guérin vaccine-related complications in children in Oman
od: Badria Al Waili, i dr.
Izdano: (2021-02-01)

Infantile osteoarticular tuberculosis misdiagnosed as Bacillus Calmette-Guerin related osteomyelitis
od: Limpaphayom Noppachart, i dr.
Izdano: (2015-01-01)

Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study
od: Fletcher, H, i dr.
Izdano: (2016)

A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette–Guérin-vaccinated Individuals
od: Delfina Peña, i dr.
Izdano: (2015-08-01)

Bacillus Calmette–Guérin Immunotherapy for Cancer
od: Fabíola Cardillo, i dr.
Izdano: (2021-05-01)

Evaluation of the specificity of an intradermal test with recombinant tuberculosis allergen in Bacillus Calmette–Guérin-vaccinated healthy volunteers
od: Irina A. Vasilyeva, i dr.
Izdano: (2023-03-01)

Effectiveness Of Bacillus Calmette Guerin (BCG) Vaccination In The Prevention Of Tuberculosis Of Skin : A Case Control Study.
od: Zodpey S.P, i dr.
Izdano: (1998-01-01)

Optimization of a human bacille Calmette-Guerin challenge model: a tool to evaluate antimycobacterial immunity
od: Minhinnick, A, i dr.
Izdano: (2015)

The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines.
od: Paola Villanueva, i dr.
Izdano: (2022-01-01)

Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin
od: Sara Feola, i dr.
Izdano: (2021-07-01)

Research progress in the off-target effects of Bacille Calmette–Guérin vaccine
od: Yanfei Wu, i dr.
Izdano: (2024-09-01)

The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
od: Junli Li, i dr.
Izdano: (2021-01-01)

Past, Present and Future of Bacillus Calmette-Guérin Vaccine Use in China
od: Junli Li, i dr.
Izdano: (2022-07-01)